BeyondSpring Announces First Patient Dosed with Pembrolizumab,PlinabulinPlus EtoposidePlatinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-StageSmall-Cell Lung Cancer

BYSI Stock  USD 1.56  0.08  4.88%   
Under 53% of BeyondSpring's investor base is interested to short. The analysis of the overall investor sentiment regarding BeyondSpring suggests that many traders are impartial. BeyondSpring's investing sentiment shows overall attitude of investors towards BeyondSpring.
  
FLORHAM PARK, N.J., March 25, 2024 -- BeyondSpring Inc. , a clinical-stage global...

Read at globenewswire.com
Macroaxis News: globenewswire.com
  

BeyondSpring Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards BeyondSpring can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

BeyondSpring Fundamental Analysis

We analyze BeyondSpring's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeyondSpring using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeyondSpring based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Asset

Current Asset Comparative Analysis

BeyondSpring is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

BeyondSpring Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BeyondSpring stock to make a market-neutral strategy. Peer analysis of BeyondSpring could also be used in its relative valuation, which is a method of valuing BeyondSpring by comparing valuation metrics with similar companies.

Peers

BeyondSpring Related Equities

SLSSellas Life   10.15   
0%
60.0%
MCRBSeres Therapeutics   6.85   
0%
40.0%
SCPHScpharmaceuticals   1.57   
0%
9.0%
SRZNSurrozen   1.44   
0%
8.0%
INKTMink Therapeutics   0.16   
0%
1.0%
RVPHReviva Pharmaceuticals   0.00   
0%
0%
EYPTEyepoint Pharmaceuticals   0.00   
0%
0%
ALVRAllovir     
1.0%
0%
PLXProtalix Biotherapeutics   1.11   
6.0%
0%
KTTAPasithea Therapeutics   1.51   
8.0%
0%
MISTMilestone Pharmaceuticals   3.23   
19.0%
0%
ONCYOncolytics Biotech   3.57   
21.0%
0%
ARMPArmata Pharmaceuticals   6.85   
40.0%
0%
CADLCandel Therapeutics   9.63   
57.0%
0%
ADTXAditxt   12.26   
72.0%
0%
FBRXForte Biosciences   16.80   
100.0%
0%

Complementary Tools for BeyondSpring Stock analysis

When running BeyondSpring's price analysis, check to measure BeyondSpring's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeyondSpring is operating at the current time. Most of BeyondSpring's value examination focuses on studying past and present price action to predict the probability of BeyondSpring's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeyondSpring's price. Additionally, you may evaluate how the addition of BeyondSpring to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets